Abstract:Background: Systemic lupus erythematosus (SLE) is a systemic autoimmune disease involving multiple organs throughout the body. The health care-seeking behaviors, disease progression of SLE, and patients' knowledge of and attitudes toward SLE have not been characterized in China. Objective: The aim of this study was to depict the health care-seeking behaviors, disease progression, and medications in patients with SLE and to examine the factors associated with their disease flares, knowledge, and attitudes toward SLE in China. Methods: We conducted a cross-sectional survey in 27 provinces in China. Descriptive statistical methods were used to depict the demographic characteristics, health care-seeking behaviors, medications, and health status. Multivariable logistic regression models were used to identify the factors associated with disease flares, medication changes, and attitudes toward SLE. An ordinal regression model was used to examine the factors associated with the knowledge of the treatment guidelines. Results: We recruited 1509 patients with SLE, and 715 had lupus nephritis (LN). Approximately 39.96% (603/1509) of the patients with SLE were primarily diagnosed with LN, and 12.4% (112/906) developed LN (mean time 5.2 years) from non-LN. Patients whose registered permanent residences or workplaces in other cities from the same province and adjacent provinces seeking health care accounted for 66.9% (569/850) and 48.8% (479/981) of the patients with SLE in the provincial capital cities, respectively. Mycophenolate mofetil was the most commonly used immunosuppressive drug in patients without LN (185/794, 23.3%) and patients with LN (307/715, 42.9%). Femoral head necrosis (71/228, 31.1%) and hypertension (99/229, 43.2%) were the most common adverse event (AE) and chronic disease during treatment, respectively. Change of hospitals for medical consultation (odds ratio [OR] 1.90, 95% CI 1.24-2.90) and development of 1 chronic disease (OR 3.60, 95% CI 2.04-6.24) and AE (OR 2.06, 95% CI 1.46-2.92) and more were associated with disease flares. A pregnancy plan (OR 1.58, 95% CI 1.18-2.13) was associated with changes in medication. Only 242 (16.03%) patients with SLE were familiar with the treatment guidelines, and patients with LN tended to be more familiar with the disease (OR 2.20, 95% CI 1.81-2.68). After receiving treatment, 891 (59.04%) patients changed their attitudes toward SLE from fear to acceptance, and patients with college education or higher (OR 2.09, 95% CI 1.10-4.04) were associated with a positive attitude toward SLE. Conclusions: A large proportion of patients seeking health care in the provincial capital cities of China migrated from other cities. Persistent monitoring of potential AEs and chronic diseases during SLE treatment and managing patients who changed hospitals for medical consultation are essential for controlling disease flares. Patients had insufficient knowledge about SLE treatment guidelines and would benefit from health education to maintain a positive attitude toward SLE.

The Systemic Lupus Erythematosus Travel Burden Survey: Baseline Data among a South Carolina Cohort

Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.

Living with systemic lupus erythematosus in 2020: a European patient survey

An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life

Stress Intervention and Disease in African American Lupus Patients: the Balancing Lupus Experiences with Stress Strategies (BLESS) Study

OP0250 INFLUENTIAL FACTORS IN PROMOTING TREAT-TO-TARGET FOR SYSTEMIC LUPUS ERYTHEMATOSUS VIA EMPOWERING PATIENTS: A COHORT STUDY FROM CHINA BY SMART SYSTEM OF DISEASE MANAGEMENT (SSDM)

Cross-sectional survey to determine fatigue in patients with systemic lupus erythematosus

Direct medical charges in a population-based systemic lupus erythematosus cohort

Depression-, Pain-, and Health-Related Quality of Life in Patients with Systemic Lupus Erythematosus

Predictors of Non-Response and Non-Compliance in African American Lupus Patients: Findings from the Balancing Lupus Experiences with Stress Strategies (BLESS) Study.

The global burden of SLE: prevalence, health disparities and socioeconomic impact

Racial and Ethnic Disparities Within Social Determinants of Health Amongst Patients With Systemic Lupus Erythematosus

A Longitudinal Analysis of Costs Associated with Change in Disease Activity in Systemic Lupus Erythematosus

Social Support And Self-Reported Stress Levels In A Predominantly African American Sample Of Women With Systemic Lupus Erythematosus

Patient-reported outcomes and healthcare resource utilization in systemic lupus erythematosus: impact of disease activity

‘Not at Target’: Prevalence and Consequences of Inadequate Disease Control in Systemic Lupus Erythematosus—a Multinational Observational Cohort Study

Receipt of rheumatology care and lupus-specific labs among young adults with systemic lupus erythematosus: A US Medicare retention in care cohort study

Relationships between person and health factors and job characteristics in women with systemic lupus erythematosus

Health Care-Seeking Behaviors, Disease Progression, Medications, Knowledge of, and Attitudes Toward Systemic Lupus Erythematosus in China: Cross-sectional Survey Study

Factors affecting discrepancies in disease activity evaluation between patients and physicians in systemic lupus erythematosus-The importance of symptoms such as fatigue

The contributions of socioeconomic status, perceived stress, and depression to disability in adults with systemic lupus erythematosus